Drug Pipeline

Sipuleucel-T Clinical Trials

Data updated daily from ClinicalTrials.gov — last refresh 2026-06-12
3
Active Studies
2
Recruiting
3
Top Sponsors
3
Changes, 30 Days
What Changed in the Last 30 Days
DetectedTrialChange
2026-05-28 NCT05806814
Sipuleucel-T Based Autologous Cellular Immunotherapy for Advanced Prostate Cancer		 overall status: "Recruiting" → "Active Not Recruiting"
2026-05-28 NCT05806814
Sipuleucel-T Based Autologous Cellular Immunotherapy for Advanced Prostate Cancer		 Enrollment increased: 13 -> 15 participants
2026-05-28 NCT05806814
Sipuleucel-T Based Autologous Cellular Immunotherapy for Advanced Prostate Cancer		 date change Completion pushed: 2026-12 -> 2028-05-13
Active Studies by Phase
Phase 2
1
Phase 1
2
Active Trials
NCT IDTitleConditionStatus
Phase 2
NCT05751941 Study of Sipuleucel-T With or Without Continuing New Hormonal Agents in Metastatic… Prostate Cancer Recruiting
Phase 1
NCT07219147 177^Lu-PSMA-617 in Combination With Sipuleucel-T for the Treatment of Metastatic… Metastatic Castration-Resistant Prostate Adenocarcinoma Recruiting
NCT05806814 Sipuleucel-T Based Autologous Cellular Immunotherapy for Advanced Prostate Cancer Metastatic Castration-Resistant Prostate Cancer (mCRPC) Active, Not Recruiting
Sponsors Running Sipuleucel-T Trials
H. Lee Moffitt Cancer Center and Research Institute (1) University of Oklahoma (1) City of Hope Medical Center (1)
Disease Areas
Prostate Cancer (3)
Get alerts when Sipuleucel-T trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free